RiXtrema Inc. Adds Drs. Yaacov Kopeliovich and Barry Schachter to the Research Team by PR.com

VIEWS: 35 PAGES: 3

More Info
									RiXtrema Inc. Adds Drs. Yaacov Kopeliovich and Barry Schachter to the
Research Team

New York, NY, March 26, 2013 --(PR.com)-- RiXtrema, Inc. (www.rixtrema.com), a leading risk
management modeling and software provider to the investment management industry, is pleased to
announce today the addition of Dr. Yaacov Kopeliovich and Dr. Barry Schachter to the research team.

Dr. Kopeliovich, who joins RiXtrema as a Director of Research, has extensive experience with the real
world behavior of complex financial instruments during crisis events. “Yaacov's mathematical
background, his derivative experience at MEAG and his focus on overcoming the deficiencies of
traditional investment models make him an invaluable asset to RiXtrema as we continue to build
state-of-the-art tail risk systems for the 21st century,” stated Daniel Satchkov, RiXtrema's President and
Founder.

Dr. Kopeliovich added, “I am delighted to have joined such an impressive firm and a superb cast of
innovative, dedicated, and ethical individuals. I very much look forward to helping the asset management
industry in attaining a deeper understanding and better management of tail risks.”

Dr. Schachter, who is assuming a Senior Advisor role on RiXtrema's Scientific Advisory Board, is a
legendary risk manager who brings with him a wealth of experience, having spent his career leading risk
groups at a number of prominent hedge funds, including most recently as a Chief Risk Officer at
Woodbine Capital Advisors. Dr. Schachter said, “RiXtrema is truly unique in its approach to risk
analysis, and I am excited to have the opportunity to bring new and exciting research into everyday risk
management practice.”

Mr. Satchkov shared his thoughts on the addition of Dr. Schachter to the RiXtrema team, “Barry shares
our desire for innovation in risk analysis. His research and practical expertise will be applied to
developing new uses for groundbreaking products like RiXtrema's Reverse Stress Testing. He will join
experts like Dr. Jon Danielsson of LSE in working closely with Dr. Kopeliovich and the rest of the
research team to provide a fresh look at tail risks facing the asset managers.”

Dr. Schachter received his M.A. and Ph.D. from Cornell University, and received his BS from Bentley
University. Additionally, he currently serves on the Editorial Board of the Journal of Derivatives and
maintains one of the longest running risk websites at Gloria-Mundi.com. He is also a Fellow of the
Program in Mathematics in Finance at NYU's Courant Institute and a Research Associate at the EDHEC
Business School.

Dr. Kopeliovich received his Masters in Financial Engineering from the Hass School of Business at the
University of California, Berkley, his B.S., M.S. and Ph.D. in Mathematics from Hebrew University,
Jerusalem, Israel and is currently studying for his Ph.D. in Finance from EDHEC Business School, Nice,
France.

About RiXtrema, Inc.


                                                   Page 1/3
                                PR.com Press Release Distribution   Terms of Use
based in New York, is a risk management modeling and software provider to the investment management
industry. RiXtrema works with pension plans and consultants, mutual funds, hedge funds, funds of funds
and other asset managers to implement and support a carefully structured risk management process
focusing on diversification in periods of extreme volatility.

Contact

William Faulkner
Director of Strategy and Business Development
212-513-7070
wfaulkner@rixtrema.com




                                                 Page 2/3
                              PR.com Press Release Distribution   Terms of Use
Contact Information:
RiXtrema
William Faulkner
347-836-8311
Contact via Email
rixtrema.com


Online Version of Press Release:
You can read the online version of this press release at: http://www.pr.com/press-release/481578




                                                  Page 3/3
                               PR.com Press Release Distribution   Terms of Use

								
To top